D
Celldex Therapeutics, Inc. CLDX
$21.50 -$0.43-1.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 730.00K 695.00K 1.18M 3.19M 2.50M
Total Other Revenue -- -- -- -- --
Total Revenue 730.00K 695.00K 1.18M 3.19M 2.50M
Cost of Revenue 54.20M 52.61M 46.94M 45.26M 39.69M
Gross Profit -53.47M -51.92M -45.76M -42.07M -37.19M
SG&A Expenses 10.39M 10.82M 10.26M 10.05M 9.13M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 64.59M 63.43M 57.20M 55.32M 48.82M
Operating Income -63.86M -62.74M -56.03M -52.13M -46.32M
Income Before Tax -56.60M -53.80M -47.09M -42.12M -35.84M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -56.60M -53.80M -47.09M -42.12M -35.84M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -56.60M -53.80M -47.09M -42.12M -35.84M
EBIT -63.86M -62.74M -56.03M -52.13M -46.32M
EBITDA -62.98M -61.87M -55.21M -51.34M -45.52M
EPS Basic -0.85 -0.81 -0.71 -0.64 -0.54
Normalized Basic EPS -0.53 -0.51 -0.44 -0.40 -0.34
EPS Diluted -0.85 -0.81 -0.71 -0.64 -0.54
Normalized Diluted EPS -0.53 -0.51 -0.44 -0.40 -0.34
Average Basic Shares Outstanding 66.39M 66.38M 66.35M 66.29M 66.02M
Average Diluted Shares Outstanding 66.39M 66.38M 66.35M 66.29M 66.02M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --